In May 2001, Union Biometrica Inc was acquired by SBIR firm Harvard Bioscience, Inc. Union Biometrica, Inc. (UBI), develops and manufactures innovative instrumentation and biochemical tools for drug discovery and biomedical research. With expertise in physics, biology and engineering, the Company has developed patented system solutions for difficult problems in assays, detection and analysis. Focused expertise in solving problems for Pharmaceutical Applications Biotechnology Applications Using UBI Core Technologies of Flow Cytometry; High throughput analysis and sorting of complex organisms; High throughput analysis and dispensing of combinatorial chemistry beads
